Youssef M Mosaad Selected Research

Youssef M Mosaad Research Topics

Disease

2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2016 - 01/2009
2	Lupus Nephritis 01/2016 - 01/2010
2	Rheumatoid Arthritis 05/2014 - 11/2010
2	Genetic Predisposition to Disease (Genetic Predisposition) 04/2013 - 08/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 04/2013 - 01/2005
2	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2006 - 01/2005
1	Chronic Hepatitis C 04/2019
1	Hepatocellular Carcinoma (Hepatoma) 04/2019
1	Fibrosis (Cirrhosis) 04/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2019
1	Nephritis 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2015
1	Immune System Diseases (Immune Disorders) 09/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2014
1	Osteoporosis 05/2014
1	Type 2 Diabetes Mellitus (MODY) 04/2013
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 08/2012
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2012
1	Pemphigus (Pemphigus Vulgaris) 05/2012
1	Neoplasm Metastasis (Metastasis) 09/2011
1	Colorectal Neoplasms (Colorectal Cancer) 09/2011
1	Atherosclerosis 11/2010
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2009
1	Transitional Cell Carcinoma 10/2009
1	Hematologic Neoplasms (Hematological Malignancy) 01/2005
1	Hematologic Diseases (Blood Diseases) 01/2005
1	Skin Diseases (Skin Disease) 01/2004
1	Atopic Dermatitis (Atopic Eczema) 01/2004
1	Rheumatic Diseases (Rheumatism) 01/2003

Drug/Important Bio-Agent (IBA)

2	HLA Antigens (Human Leukocyte Antigens)IBA 09/2014 - 08/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2011 - 10/2009
2	AntibodiesIBA 11/2010 - 01/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2019
1	InterferonsIBA 04/2019
1	Interferon-alpha (Interferon Alfa)IBA 04/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	InterleukinsIBA 01/2016
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2015
1	HLA-A Antigens (HLA-A)IBA 09/2014
1	HLA-A28 antigenIBA 09/2014
1	HLA-B8 Antigen (HLA B8 Antigen)IBA 09/2014
1	AntigensIBA 09/2014
1	Complement System Proteins (Complement)IBA 09/2014
1	HLA-DR11 antigenIBA 09/2014
1	Calcitriol Receptors (Calcitriol Receptor)IBA 05/2014
1	methyl 4-azidophenylacetimidate (APAI)IBA 05/2014
1	Codon (Codons)IBA 04/2013
1	HLA-DQB1 antigen (HLA DQB1)IBA 08/2012
1	CholesterolIBA 08/2012
1	C-PeptideIBA 08/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012
1	Interleukin-6 (Interleukin 6)IBA 05/2012
1	Keratin-20 (Cytokeratin 20)IBA 09/2011
1	oxidized low density lipoproteinIBA 11/2010
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2010
1	Antinuclear AntibodiesIBA 01/2009
1	Minor Histocompatibility AntigensIBA 08/2006
1	HLA-DPB1 antigen (HLA DPB1)IBA 01/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2005
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2005
1	Immunoglobulin E (IgE)IBA 01/2004
1	Interleukin-13IBA 01/2004
1	Interleukin-18 (Interleukin 18)IBA 01/2003
1	Interleukin-12 (IL 12)IBA 01/2003
1	AutoantibodiesIBA 01/2003
1	CytokinesIBA 01/2003

Therapy/Procedure

2	Transplantation 09/2014 - 01/2005
1	Kidney Transplantation 09/2014
1	Urinary Diversion (Ileal Conduit) 10/2009
1	Cystectomy 10/2009
1	Stem Cell Transplantation 08/2006
1	Therapeutics 01/2005
1	Hematopoietic Stem Cell Transplantation 01/2005
1	Glycemic Control 01/2005